Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$42.45M
Expense Ratio	1.49%
PE Ratio	n/a
Forward PE	n/a
Shares Out	1.69M
Dividend	$0.70 (2.50%)
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	469,542
Open	27.74
Previous Close	26.46
Day's Range	27.49 - 29.28
52-Week Low	14.51
52-Week High	31.19
Beta	0.60
Holdings	12
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSE Arca
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

287.59% of assets

Name	Symbol	Weight
United States Treasury Bills 0%	B.0 11.19.26	66.82%
ELI LILLY & CO SWAP MS	n/a	63.30%
LLY SWAP NOMURA	n/a	26.17%
ELI LILLY AND COMPANY-SWAP-NBCB-L	n/a	25.25%
ELI LILLY & CO SWAP Cantor - L	n/a	23.85%
ELI LILLY & CO SWAP MAREX	n/a	23.50%
ELI LILLY & CO SWAP CS	n/a	20.69%
ELI LILLY & CO SWAP BMO	n/a	20.05%
US DOLLARS	n/a	10.17%
First American Government Obligs X	FGXXX	7.79%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.70417	Dec 31, 2025

Performance

LLYX had a total return of 86.22% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.79%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error